Meyka Pro banner
Resolute Holdings Management Common Stock Ex-distribution When-Issued

Stay Updated with the Latest Resolute Holdings Management Common Stock Ex-distribution When-Issued RHLDV News in Real Time

Find RHLDV news now at Meyka AI. Stay informed with the latest Resolute Holdings Management Common Stock Ex-distribution When-Issued stocks updates, including price news, market analysis, and expert insights.

RHLDVNASDAQ
IndustrialsSpecialty Business Services
$31.63
$0.19(0.60%)
U.S. Market opens in 13h 12m
Loblaw Restores Tariff Labels as Trade War Reignites August 27
📅 in about 2 hours

Loblaw Restores Tariff Labels as Trade War Reignites August 27

Loblaw reinstates tariff ‘T’ symbols and country-of-origin produce labels on August 26 amid escalating Canada-U.S. trade war and consumer pressure to support domestic suppliers.

Read more 12
Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume
📅 in about 2 hours

Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume

HYPEUSD rallied 3.2% to $85.08 on August 27 following Hyperliquid’s launch of tokenized stocks and AQAv2 buyback engine on August 26.

Read more 12
Apple Confirms iPhone 18 Pro Event for September 9, Foldable Phone Expected
📅 in about 1 hour

Apple Confirms iPhone 18 Pro Event for September 9, Foldable Phone Expected

Apple confirms September 9 event for iPhone 18 Pro and foldable iPhone launch. New CEO John Ternus debuts. Pre-orders likely September 12, retail launch September 18.

Read more 12
Malaysia’s Ex-PM Ismail Sabri Charged With Concealing $40M in Assets on August 27
📅 2 hours ago

Malaysia’s Ex-PM Ismail Sabri Charged With Concealing $40M in Assets on August 27

Ismail Sabri Yaakob, Malaysia’s shortest-serving PM, charged with concealing US$40M in undeclared assets including foreign currencies and gold bars. Faces up to 5 years prison if convicted.

Read more 12
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
📅 7 hours ago

AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial

AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…

Read more 12
Shein Sets Hong Kong IPO Price at HK$48.56, Valuing Fast-Fashion Giant at $26.5 Billion
📅 7 hours ago

Shein Sets Hong Kong IPO Price at HK$48.56, Valuing Fast-Fashion Giant at $26.5 Billion

Shein will price its Hong Kong IPO at HK$48.56 per share, people familiar with the matter said Thursday. The price sits near the midpoint of its HK$47.60 to HK$49.50 marketed range. The deal values Shein at roughly $26.5 billion, confirming weeks of investor pushback on valuation. Final Pricing Details Shein’s pricing will raise approximately HK$13.6…

Read more 12
Nvidia Beats Q2 Targets With $96.2B Revenue, Stock Falls 1.6% on August 27
📅 7 hours ago

Nvidia Beats Q2 Targets With $96.2B Revenue, Stock Falls 1.6% on August 27

Nvidia beat Q2 earnings with $96.2B revenue and $2.22 adjusted EPS, but stock fell 1.6%. Q3 guidance of $108B signals strong AI chip demand ahead.

Read more 12
IPO Subscription Today: Hy Tech Engineers Booked 114x, Skyways 14.4x and Symbiotec 13.86x
📅 8 hours ago

IPO Subscription Today: Hy Tech Engineers Booked 114x, Skyways 14.4x and Symbiotec 13.86x

IPO subscription today has put Hy Tech Engineers in focus, with the issue reportedly booked 114 times on August 27, 2026. Skyways Air and Symbiotec Pharmalab also saw strong investor demand, with subscriptions of 14.4 times and 13.86 times, respectively. The wide gap between the three issues shows where investors are placing the strongest bets….

Read more 12
Meta (META) $18 Billion Settlement Escalates Global Fight Over Social Media Harm to Teens
📅 8 hours ago

Meta (META) $18 Billion Settlement Escalates Global Fight Over Social Media Harm to Teens

Meta agreed on August 26, 2026, to pay up to $18 billion to settle claims that Facebook and Instagram were designed in ways that harmed young users. The deal also brings strict new limits for teenagers, including daily usage caps and overnight restrictions. But the settlement reaches beyond Meta. It could increase pressure on TikTok,…

Read more 12

RHLDV News FAQ